New Strong Sell Stocks for February 20th
ASGN, ADNT and AFG have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.
New Strong Sell Stocks for February 10th
ASGN, AHEXY and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on February 10, 2025.
New Strong Sell Stocks for February 6th
ADNT, AOS and BASFY have been added to the Zacks Rank #5 (Strong Sell) List on February 6, 2025.
Adient: Encouraging Near-Term Trends But Elevated Risk Remains
Adient's ultra-low gross margin and high costs remain concerning despite recent share price gains and positive Q1 earnings, warranting a cautious investment stance. The company's financials are under pressure due to low production volumes and potential impacts from upcoming US tariffs and major restructuring needs in EMEA. Negative GAAP earnings and declining book value, despite stock buybacks, highlight challenges in managing working capital and sustaining cash flow.
Adient Q1 Earnings Surpass Expectations, FY25 Sales View Cut
ADNT reports better-than-expected fiscal Q1 results. It expects fiscal 2025 revenues to be $13.9 billion, down from the previous estimate of $14.1-$14.4 billion.
Adient plc (ADNT) Q1 2025 Earnings Call Transcript
Adient plc (NYSE:ADNT ) Q1 2025 Earnings Conference Call January 28, 2025 8:00 AM ET Company Participants Michael Heifler - VP, IR and Strategy Jerome Dorlack - President and CRO Mark Oswald - EVP and CFO Conference Call Participants Dan Levy - Barclays Jake Scholl - BNP Paribas Kosta Tasoulis - Wells Fargo Operator Welcome and thank you for standing by. At this time all participants are in a listen-only mode.
Adient (ADNT) Q1 Earnings and Revenues Top Estimates
Adient (ADNT) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.31 per share a year ago.
Best Value Stocks to Buy for January 21st
NGVT, ICL and ADNT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2025.
Adient downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Adient to Equal Weight from Overweight with a price target of $20, down from $27. The firm likes the long-term story but says the company's near-term outlook is challenged with European market weakness. This places risk on Adient's 2025 outlook, the analyst tells investors in a research note.
Adient: Need Clarity On Trump's Policies Before Buying
Adient plc's FY2024 results showed a -5% YoY revenue decline, with challenges in the Americas and EMEA regions but growth in Asia, especially China. The FY2025 outlook predicts continued revenue decline, with strategic restructuring in Europe and growth initiatives in China to counterbalance market headwinds. Despite a tough competitive environment, ADNT maintains margin stability and trades at favorable valuations, with a forward P/E ratio of 10.2x.
New Strong Sell Stocks for November 15th
ADNT, WMS and BATRA have been added to the Zacks Rank #5 (Strong Sell) List on November 15, 2024.
Adient Q4 Earnings Surpass Expectations, Revenues Decline Y/Y
ADNT reports better-than-expected Q4 results and expects fiscal 2025 revenues in the range of $14.1-$14.4 billion, down from $14.69 billion reported in 2024.
